Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Farbod, Darvishian"'
Autor:
Veronica Davalos, Claudia D. Lovell, Richard Von Itter, Igor Dolgalev, Praveen Agrawal, Gillian Baptiste, David J. Kahler, Elena Sokolova, Sebastian Moran, Laia Piqué, Eleazar Vega-Saenz de Miera, Barbara Fontanals-Cirera, Alcida Karz, Aristotelis Tsirigos, Chi Yun, Farbod Darvishian, Heather C. Etchevers, Iman Osman, Manel Esteller, Markus Schober, Eva Hernando
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Melanocytes can de-differentiate into neural crest cell (NCC)- like states during metastatic melanoma progression. Here the authors compare DNA methylation profiles of NCCs and melanocytes, as well as primary and metastatic patient tissues and identi
Externí odkaz:
https://doaj.org/article/8185f7446ad34fda88510e094a1353e3
Autor:
Farbod Darvishian, Yinxiang Wu, Ugur Ozerdem, Jennifer Chun, Sylvia Adams, Amber Guth, Deborah Axelrod, Richard Shapiro, Andrea B. Troxel, Freya Schnabel, Daniel Roses
Publikováno v:
Breast, Vol 64, Iss , Pp 35-40 (2022)
Introduction: There is evidence that supports the association of dense tumor infiltrating lymphocyte (TILs) with an increased risk of ipsilateral recurrence in ductal carcinoma in situ (DCIS). However, the association of cellular composition of DCIS
Externí odkaz:
https://doaj.org/article/51d9f4b28bf645b88cca501e0a2c27ee
Autor:
Tess V. Clendenen, Wenzhen Ge, Karen L. Koenig, Yelena Afanasyeva, Claudia Agnoli, Louise A. Brinton, Farbod Darvishian, Joanne F. Dorgan, A. Heather Eliassen, Roni T. Falk, Göran Hallmans, Susan E. Hankinson, Judith Hoffman-Bolton, Timothy J. Key, Vittorio Krogh, Hazel B. Nichols, Dale P. Sandler, Minouk J. Schoemaker, Patrick M. Sluss, Malin Sund, Anthony J. Swerdlow, Kala Visvanathan, Anne Zeleniuch-Jacquotte, Mengling Liu
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-12 (2019)
Abstract Background Models that accurately predict risk of breast cancer are needed to help younger women make decisions about when to begin screening. Premenopausal concentrations of circulating anti-Müllerian hormone (AMH), a biomarker of ovarian
Externí odkaz:
https://doaj.org/article/5173ace532a544d39c8c04eefe3f07c5
Autor:
Lawrence H. Lin, Ivy Tran, Yiying Yang, Paolo Cotzia, Daniel Roses, Freya Schnabel, Farbod Darvishian, Matija Snuderl
Publikováno v:
Cancer Research. 83:P2-23
Background: Triple negative breast cancers (TNBC) are characterized by the absence of estrogen receptors, progesterone receptors, and HER2 receptors on immunohistochemical analysis (IHC). This subtype of breast cancer has been traditionally associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c4d17b16874b4684343d9af73ec4d4e
https://doi.org/10.1158/1538-7445.sabcs22-p2-23-07
https://doi.org/10.1158/1538-7445.sabcs22-p2-23-07
Autor:
Eva Hernando, Iman Osman, Anna C. Pavlick, Richard L. Shapiro, Russell S. Berman, Farbod Darvishian, Douglas Hanniford, Avital Gaziel, Jan Zakrzewski, Amy E. Rose, Ilana Belitskaya-Lévy, Miguel F. Segura
Purpose: To identify a melanoma microRNA (miRNA) expression signature that is predictive of outcome and then evaluate its potential to improve risk stratification when added to the standard-of-care staging criteria.Experimental Design: Total RNA was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333f15fc0806382d3bc8b3c1731b1979
https://doi.org/10.1158/1078-0432.c.6518724.v1
https://doi.org/10.1158/1078-0432.c.6518724.v1
Autor:
Eva Hernando, Iman Osman, Yongzhao Shao, Farbod Darvishian, Russell Berman, Richard Shapiro, Anna Pavlick, Shulian Shang, Daniel J. Lackaye, Avital Gaziel-Sovran, Lisa Koetz, Judy Zhong, Doug Hanniford
Supplementary Figure S2. This figure depicts brain metastatsis-free and overall survival, as plotted kaplan-meier survival curves, of high- vs low-risk patients (determined by the miRNA signature + stage model) for patients stratified by stage at dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0b909430d9d5d14bc63bd272cd7380
https://doi.org/10.1158/1078-0432.22458140.v1
https://doi.org/10.1158/1078-0432.22458140.v1
Autor:
Ashani T. Weeraratna, Iman Osman, Douglas B. Johnson, Jennifer L. McQuade, Alexander M. Menzies, Ravi K. Amaravadi, Wei Xu, Dirk Schadendorf, Bastian Schilling, Michael A. Davies, Zeynep Eroglu, Antoni Ribas, Richard Marais, Georgina V. Long, Matteo S. Carlino, Rajat Rai, Jeffrey Sosman, Theodore S. Nowicki, Erica L. Stone, Dmitry Gabrilovich, Jose R. Conejo-Garcia, Meenhard Herlyn, Alpaslan Ozgun, Siwen Hu-Lieskovan, Rajasekharan Somasundaram, Daniel Y. Wang, Vinit Kumar, Nikolaos Svoronos, Michael J. Allegrezza, Mitchell Fane, Brett L. Ecker, Gretchen M. Alicea, Reeti Behera, Abibatou Ndoye, Rami N. Al-Rohil, Farbod Darvishian, Sarah A. Weiss, Xiangfan Yin, Qin Liu, Amanpreet Kaur, Marie R. Webster, Stephen M. Douglass, Curtis H. Kugel
PDF containing all supplementary figures. Supplementary Figure Legends. Supplemental Figure 1. A, graph indicating the number of patients for which best response data to pembrolizumab was obtained, and from which institution. B, various response grou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52509a2fdc5abd55620cd2305dfef269
https://doi.org/10.1158/1078-0432.22475571
https://doi.org/10.1158/1078-0432.22475571
Autor:
Ashani T. Weeraratna, Iman Osman, Douglas B. Johnson, Jennifer L. McQuade, Alexander M. Menzies, Ravi K. Amaravadi, Wei Xu, Dirk Schadendorf, Bastian Schilling, Michael A. Davies, Zeynep Eroglu, Antoni Ribas, Richard Marais, Georgina V. Long, Matteo S. Carlino, Rajat Rai, Jeffrey Sosman, Theodore S. Nowicki, Erica L. Stone, Dmitry Gabrilovich, Jose R. Conejo-Garcia, Meenhard Herlyn, Alpaslan Ozgun, Siwen Hu-Lieskovan, Rajasekharan Somasundaram, Daniel Y. Wang, Vinit Kumar, Nikolaos Svoronos, Michael J. Allegrezza, Mitchell Fane, Brett L. Ecker, Gretchen M. Alicea, Reeti Behera, Abibatou Ndoye, Rami N. Al-Rohil, Farbod Darvishian, Sarah A. Weiss, Xiangfan Yin, Qin Liu, Amanpreet Kaur, Marie R. Webster, Stephen M. Douglass, Curtis H. Kugel
Figure Legends for Supplemental Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39be785a3c13bcce774fc0327250b89b
https://doi.org/10.1158/1078-0432.22475574.v1
https://doi.org/10.1158/1078-0432.22475574.v1
Autor:
David Polsky, Iman Osman, Judith D. Goldberg, Linda Rolnitzky, Farbod Darvishian, Hideko Kamino, Julide Tok Celebi, Harry Ostrer, Prashiela Manga, Anna Pavlick, Russell Berman, Richard Shapiro, Guimin Wang, Danuta Pollens, Jan Zakrzewski, Melanie Warycha, Elnaz F. Firoz
Purpose: In certain cancers, MDM2 SNP309 has been associated with early tumor onset in women. In melanoma, incidence rates are higher in women than in men among individuals less than 40 years of age, but among those older than 50 years of age, melano
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11b73c9ae5e18ce307390010e2b0185e
https://doi.org/10.1158/1078-0432.c.6517999.v1
https://doi.org/10.1158/1078-0432.c.6517999.v1
Autor:
Eva Hernando, Iman Osman, Yongzhao Shao, Farbod Darvishian, Russell Berman, Richard Shapiro, Anna Pavlick, Shulian Shang, Daniel J. Lackaye, Avital Gaziel-Sovran, Lisa Koetz, Judy Zhong, Doug Hanniford
Purpose: Brain metastasis is the major cause of mortality among patients with melanoma. A molecular prognostic test that can reliably stratify patients at initial melanoma diagnosis by risk of developing brain metastasis may inform the clinical manag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7b559f37e2892ef1b8d9c22906ae21
https://doi.org/10.1158/1078-0432.c.6523844
https://doi.org/10.1158/1078-0432.c.6523844